Hims & Hers Health, Inc. reported a revenue increase of 79% year-over-year to $74.2 million for Q3 2021. Ending member subscriptions grew 95% year-over-year to 551,000. The company exceeded its Q3 2021 revenue guidance and raised its full year 2021 guidance.
Revenue was $74.2 million, up 79% year-over-year.
Net loss was $(15.9) million compared to $(5.9) million for the third quarter 2020.
Gross margin was 74% compared to 76% for the third quarter 2020.
Adjusted EBITDA was $(9.8) million compared to $(1.6) million for the third quarter 2020.
For the fourth quarter 2021, Hims & Hers expects revenue to be in the range of $76 million to $78 million, and Adjusted EBITDA to be in the range of $(12) million to $(14) million. For the full year 2021, the company expects revenue to be in the range of $263 million to $265 million, and Adjusted EBITDA to be in the range of $(35) million to $(37) million.
Visualization of income flow from segment revenue to net income